Risk Factors for Rate of Decline in FEV1 in Adults With Cystic Fibrosis

Journal of Cystic Fibrosis - Netherlands
doi 10.1016/j.jcf.2012.03.009
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Elsevier BV

Related search

Clinical Use of Dornase Alfa Is Associated With a Slower Rate of FEV1 Decline in Cystic Fibrosis

Pediatric Pulmonology
Child HealthPulmonaryPediatricsPerinatologyRespiratory Medicine
2011English

Risk Factors for Lung Disease Progression in Children With Cystic Fibrosis

European Respiratory Journal
MedicinePulmonaryRespiratory Medicine
2018English

Risk of Post-Lung Transplant Renal Dysfunction in Adults With Cystic Fibrosis

Chest
CardiologyCritical CareCardiovascular MedicineIntensive Care MedicinePulmonaryRespiratory Medicine
2012English

P239 Radiation Exposure in Adults With Cystic Fibrosis

Thorax
PulmonaryRespiratory Medicine
2011English

Risk Factors for Acute Kidney Injury During Aminoglycoside Therapy in Patients With Cystic Fibrosis

Pediatric Nephrology
Child HealthPediatricsPerinatologyNephrology
2015English

Assessing Disease Disclosure in Adults With Cystic Fibrosis: The Adult Data for Understanding Lifestyle and Transitions (ADULT) Survey Disclosure of Disease in Adults With Cystic Fibrosis

BMC Pulmonary Medicine
PulmonaryRespiratory Medicine
2010English

Lung Clearance Index in Adults and Children With Cystic Fibrosis

Chest
CardiologyCritical CareCardiovascular MedicineIntensive Care MedicinePulmonaryRespiratory Medicine
2016English

Vitamin D and Bone Health in Adults With Cystic Fibrosis

Clinical Endocrinology
EndocrinologyMetabolismDiabetes
2008English

A 3-Year Prognostic Score for Adults With Cystic Fibrosis

Journal of Cystic Fibrosis
Child HealthPulmonaryPediatricsPerinatologyRespiratory Medicine
2017English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy